(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMA &

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PHARMA &

ST13

US500000090800714

Class

35, 42

Filing

90800714

Registration

7058254

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

09/13/2023

Trademark type

Combined

Nice classes

35, 42

Filing date

06/29/2021

Registration date

05/23/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/23/2023

Last transaction

05/23/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

27

Owner location

WIEN, AT

Examiner

COLEMAN,CIMMERIAN

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "PHARMA &" in purple.

Holders and representatives

Holders

PHARMAAND GMBH
zr pharma& GmbH

Representatives

Matthew A. Homyk BLANK ROME LLP

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies

Class 42

Drug discovery services; Pharmaceutical research and development; Providing information about medical and scientific research; Research and development and consultation related thereto in the field of pharmaceutical research; Scientific research consulting in the field of pharmaceutical research

Publications

History of USPTO decisions and trademark events.

31 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/13/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/23/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/23/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/07/2023

PUBO

PUBLISHED FOR OPPOSITION

03/07/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/15/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/12/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/12/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/12/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/12/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/12/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/12/2022

OTHE

CASE RETURNED TO EXAMINATION

11/04/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

11/04/2022

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

11/04/2022

APET

ASSIGNED TO PETITION STAFF

10/31/2022

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

10/04/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/23/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/28/2022

PUBO

PUBLISHED FOR OPPOSITION

06/28/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/08/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/24/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/19/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/19/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/28/2022

GNRT

NON-FINAL ACTION E-MAILED

03/28/2022

CNRT

NON-FINAL ACTION WRITTEN

03/28/2022

DOCK

ASSIGNED TO EXAMINER

03/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/10/2021

NWAP

NEW APPLICATION ENTERED

07/02/2021

Continuous trademark protection

Get notified about every new filing that threatens PHARMA & or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.